<- Go Home
Pheton Holdings Ltd
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is headquartered in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.
Market Cap
$441.2M
Volume
180.5K
Cash and Equivalents
$6.2M
EBITDA
-$757.6K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$381.2K
Profit Margin
85.04%
52 Week High
$32.00
52 Week Low
$1.32
Dividend
N/A
Price / Book Value
71.33
Price / Earnings
-596.22
Price / Tangible Book Value
71.33
Enterprise Value
$435.3M
Enterprise Value / EBITDA
-623.74
Operating Income
-$770.3K
Return on Equity
20.35%
Return on Assets
-11.54
Cash and Short Term Investments
$6.2M
Debt
$248.0K
Equity
$6.2M
Revenue
$448.2K
Unlevered FCF
-$1.5M
Sector
Health Care Technology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium